repligen.com (RGEN) Year-over-year earnings per share growth for the last twelve months
Repligen Corporation (RGEN) possesses immense pricing power due to the deep integration of its systems into customers' production cycles. GURU.Markets analytics provides this chart, where the quarterly EPS change reaches -358.90, confirming financial stability. Revenues are based on the sale of chromatography and filtration equipment. Stable demand and a scientific approach to quality attract the best technologists to the company.
Analytical breakdowns for Repligen Corporation
- share price and expert price forecast:
- market capitalization details:
- book capitalization data:
- debt and solvency information:
- earnings and valuation multiples information:
RGEN - Final Profit|Projected Future Earnings Repligen Corporation|RGEN - P/E Multiple|Projected Price to Earnings Repligen Corp.|RGEN - Company Value to Earnings Growth Ratio|EV/EBITDA Multiple Repligen Corp.|RGEN - Operating income before deduction of amortization|Earnings per share for the last twelve months Repligen|RGEN - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months repligen.com|RGEN - Earnings per share growth this year|Net earnings per share growth forecast for next year Repligen Corporation
Summary company analytics:Repligen Corporation
The efficiency of Repligen Corporation (RGEN) production and logistics outsourcing is directly reflected in the historical quarterly EPS growth trend. This indicator measures the percentage change in net profit per share over the last three months. The calculation allows for an assessment of the real business scaling speed, stripped of market volatility. A positive trend confirms the profitability of the operating model, although a sharp spike in the curve may signal the risk of overpaying for the asset.
Competing companies
TEM: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Qiagen NV (QGEN)|Year-over-year earnings per share growth for the last twelve months Ionis Pharma|Year-over-year earnings per share growth for the last 12 months RNA (Avidity Corp)|Year-over-year net earnings per share growth for the last 12 months CRSP (CRISPR Therapeutics AG)|WGS (genedx.com) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth RARE (Ultragenyx)|BEAM - Year-over-year net earnings per share growth for the last 12 months|SRPT - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months Twist Bioscience Corp|10x Genomics, Inc. (TXG) - Year-over-year earnings per share growth for the last twelve months|intelliatx.com - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Stoke Therapeutics, Inc.|BioLife Solutions Inc - Year-over-year net earnings per share trend for the last twelve months|Year-over-year earnings per share growth for the last twelve months Wave Life Sciences Corp (WVE)|MAZE - Earnings per share growth in annualized terms for the last twelve months|Year-over-year earnings per share growth for the last twelve months Sionna Therapeutics Inc SION|Year-over-year earnings per one share growth for the last 12 months PRME|Taysha Gene Therapies, Inc. - Quarterly EPS earnings growth|QURE - Quarterly EPS earnings growth|MGTX (MeiraGTx PLC) - Year-over-year net earnings per share growth for the last 12 months|RGNX: Year-over-year earnings per share growth rate for the last twelve months|SLDB (Solid Biosciences Inc.) - Quarterly EPS earnings growth|ocugen.com (OCGN) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months PacBio (PACB)|BNTC - Earnings per share growth in annualized terms for the last twelve months|Year-over-year earnings per share growth for the last twelve months Design Pharma DSGN|RCKT: Year-over-year earnings per share growth for the last 12 months|FDMT - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per one share growth for the last 12 months LXEO (Lexeo Therapeutics)|KRRO: Quarterly EPS earnings growth|Net earnings per share growth for the trailing year Editas Medicine Inc EDIT|SLN (Silence Therapeutics Inc.) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months ProQR Therapeutics NV PRQR|Year-over-year earnings per share growth for the last twelve months Codexis, Inc. (CDXS)|sangamo.com - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth NAUT (Nautilus Bio)|MGX: Year-over-year earnings per share growth for the last 12 months|DTIL - Year-over-year earnings per share growth for the last twelve months|GBIO (Generation Bio Co.) - Year-over-year earnings per share growth for the last 12 months|BOLD: Quarterly EPS earnings growth|Exicure (XCUR) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months Imunon Inc|PHIO: Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth MBIO|RNAZ - Earnings per share growth in annualized terms for the last twelve months|Year-over-year earnings per share growth for the last twelve months Bionano Genomics BNGO|APDN (adnas.com) - Year-over-year net earnings per share trend for the last twelve months|BLUE - Year-over-year earnings per share growth for the last twelve months|IPA: Year-over-year earnings per share growth for the last twelve months|OMGA: Quarterly EPS earnings growth|OMIC - Year-over-year net earnings per share change for the last twelve months|RGLS (Regulus Therapeutics) - Quarterly EPS earnings growth|SYRS - Net earnings per share growth for the trailing year|Quarterly EPS earnings growth TBIO|TCON - Earnings per share growth in annualized terms for the last twelve months|Year-over-year earnings per share growth for the last twelve months Unity Bio UBX
